Inflection Point Acquisition Corp. III (IPCX)
NASDAQ: IPCX · Real-Time Price · USD
10.48
-0.01 (-0.10%)
Aug 13, 2025, 9:30 AM - Market open

Akoya Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024
Period Ending
Aug '25 Dec '24
350-
Enterprise Value
350-
Debt / Equity Ratio
-1.02-2.09
Current Ratio
0.010.02
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q